linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Astrazeneca Pharma India Ltd.
 
Source DateBoard Meeting DateDetails
01 Feb 202611 Feb 2026 Quarterly Results
27 Oct 202507 Nov 2025 Quarterly Results
24 Jul 202514 Aug 2025 Quarterly Results
21 May 202530 May 2025 Dividend & Audited Results
20 Jan 202511 Feb 2025 Quarterly Results
25 Oct 202413 Nov 2024 Quarterly Results
24 Jul 202408 Aug 2024 Quarterly Results
15 May 202427 May 2024 Dividend & Audited Results
25 Jan 202408 Feb 2024 Quarterly Results
30 Oct 202309 Nov 2023 Quarterly Results
04 Aug 202314 Aug 2023 Quarterly Results
23 May 202330 May 2023 Dividend & Audited Results
30 Jan 202310 Feb 2023 Quarterly Results
31 Oct 202211 Nov 2022 Quarterly Results
01 Aug 202208 Aug 2022 Quarterly Results
18 May 202226 May 2022 Final Dividend & Audited Results
01 Feb 202208 Feb 2022 Quarterly Results
02 Nov 202109 Nov 2021 Quarterly Results
02 Aug 202109 Aug 2021 Quarterly Results & Interim Dividend
19 May 202125 May 2021 Audited Results
Page 1 of 6
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.